ROUND TABLE · 2015
2015 – Pharmacoeconomy & opportunities for the pharmaceutical sector
Pharmacoeconomy & opportunities for the pharmaceutical sector
Session program
About this session
Treatments, accommodate existing local actors in a growing market and push. Need for the country to find a way to ensure regular access to innovative.
Government priorities, which currently include massive expansion of Algeria's domestic production capacity
Attending experts
Mondher Toumi
Professor of health economics at the medical school of the University of Aix-Marseille, responsible for the pharmaco-economy departement
Richard Torbett
Chief Economist, EFPIA (The EuropeanFederation Of Pharmaceutical Industries and Associations)
Audience
- Director General of Pharmacy, MOH, Dr. Hamou Hafed
- Director General of Health, MOH, Pr. Mohamel l’Hadj
- General Manager of PCH, M’hamed Ayad
- Director General of Social Security, Djaouad Bourkaib & Dr. Mohamed Lamine Ghanem
- Ministry of Industry
- Senior management of companies & healthcare sector representative : Novo Nordisk, AstraZeneca, Clinica Group, Merck, ANPP, Deloitte, Sevier
- Chambers of Commerce: CCIAF, USABC